Similar companies
Income Statement (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Gross Profit | -2,300 | 99.7% |
| Cost of Revenue | 2,300 | 99.7% |
| Operating expense | 400,000 | 52% |
| Net Income | -450,000 | 266.5% |
| EBITDA | -400,000 | 15.4% |
Balance Sheet (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Total Assets | 3.3M | 83.1% |
| Total Liabilities | 4.9M | 42.8% |
| Shares Outstanding | 16M | 360.5% |
Cash Flow (USD)
| Q2 '24 | QoQ | |
|---|---|---|
| Cash from operations | -550,000 | 46.8% |
| Cash from investing | -53,000 | 23.6% |
| Cash from financing | 1.6M | 472% |
EPS
Financial Highlights for Anew Medical in Q2 '24
Gross Profit stood at -2,300, marking a 99.7% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 2,300, a -99.7% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 400,000, showing a -52% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -450,000, showing a -266.5% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -400,000, showing a -15.4% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Anew Medical faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. A decline in EBITDA signals potential operational challenges or increased costs.
